ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 28, 2025
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-02-26$479.61/sh−5,954$2,855,598→ 34,246 total - Sale
Common Stock
2025-02-27$480.00/sh−1,272$610,560→ 32,974 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.